A Trial of Low Doses of Risperidone in the Treatment of Patients with First-Episode Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

Journal of Clinical Psychopharmacology

Volumn 24, Issue 2, 2004, Pages 220-224

  Huq, Zahid Ul ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; AUTOMUTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; THOUGHT DISORDER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 1642406111     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000115663.45074.8a     Document Type: Article

References (13)

1. Loebel AD, Lieberman J, Alvir JMJ, et al. Duration of psychosis and outcome in first-episode schizophrenia. Arch Gen Psychiatry. 1992;149: 1183-1188.
2. Cole JO, Goldberg SC, Klerman GL. Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry. 1964;10:246-261.
3. Scottish Schizophrenia Research Group. The Scottish first-episode schizophrenia study: II. Treatment: pimozide versus flupentixol. Br J Psychiatry. 1987;153:519-525.
4. Lieberman J, Jody D, Geisler S, et al. Treatment outcome of first episode schizophrenia patients. Psychopharmacol Bull. 1989;25:92-96.
5. Chakos MH, Mayerhoff DI, Loebel AD, et al. Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacol Bull. 1992;28:81-86.
6. Syzmanski SR, Cannon TD, Gallacher F, et al. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry. 1996;153:519-525.
7. Chouinard G, Jones B, Remington G, et al. A Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol. 1993;13:25-40.
8. Kopala L, Fredrikson D, Good KP, et al. Symptoms in neuroleptic naive, first episode schizophrenia: response to risperidone. Soc Biol Psychiatry. 1996;39:296-298.
9. Kopala L, Good KP, Fredrikson D, et al. Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs. Int J Psychiatry Clin Pract. 1998;2:S19-S25.
10. Emsley RA and the Risperidone Working Group. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicentre study. Schizophr Bull. 1999;25:721-729.
11. Kopala L, Good KP, Honer WG. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low dose risperidone. J Clin Psychopharmacol. 1997;17:308-313.
12. Kontaxakis VP, Havaki-Kontaxaki BJ, Stamouli SS, et al. Optimal risperidone dose in drug naive first episode schizophrenia. Am J Psychiatry. 2000;151:1819-1821.
13. McCreadie RG, Kamath S, Padmavathy R, et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry. 1996;168:221-226.